Zydus Cadila completes dosing in Phase I clinical trial of ZyCoV-D
Phase II trial to commence on August 6, 2020
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Research
Vopec Pharma completes COVID-19 clinical trials of herbal formulation, Amrta Karuna
It reports a reduction of hospitalisation by 28 per cent
AbbVie, Amgen and Takeda jointly study impact of anti-inflammatory drugs in COVID-19 treatment
I-SPY COVID will evaluate the impact of cenicriviroc, otezla, and firazyr on inflammatory response in severely ill, hospitalised…
Study reveals macular degeneration can intensify severity of COVID-19
Existing drugs that inhibit the complement system could help treat patients with severe disease
J&J begins human trials of COVID-19 vaccine
It will test its vaccine candidate in more than 1,000 healthy adults aged 18 to 55 years, as well as adults aged 65 years and…
Empagliflozin meets primary endpoint in Phase III heart failure trial
It reduced the risk of cardiovascular death or hospitalisation for heart failure versus placebo on top of standards of care in…
Piramal Pharma Solutions to provide Bolt Biotherapeutics with immune-stimulating antibody conjugates…
Bolt’s Boltbody Immune Stimulating Antibody Conjugate (ISAC), BDC-1001, is currently in a first-in-human Phase 1/2 clinical study…
Pfizer-BioNTech to commence late stage study of COVID-19 vaccine candidate
The study is expected to include about 120 sites globally and up to 30,000 participants
SII enrols 6000 subjects for efficacy trial of rBCG vaccine, VPM1002 against COVID-19
The DBT-BIRAC supported trial aims to evaluate the ability of VPM1002 in reducing infection incidence and severe disease outcomes…
Map of ammonium’s journey may prevent infection
By improving our understanding of the normal function of ammonium transporters, we can gain insight into how specific malfunctions…
Researchers identify 21 existing drugs that block coronavirus in lab studies
The study said that four of these compounds could work in combination with remdesivir, a current standard-of-care treatment for…
DBT seed funds Gennova Biopharmaceuticals’ novel mRNA-based COVID-19 vaccine candidate
The clinical trials for the vaccine are likely to start before the year ends
Glenmark announces top-line results from Phase 3 clinical trial of favipiravir for COVID-19…
The study evaluated the efficacy and safety of favipiravir plus standard supportive care, versus standard supportive care alone,…
COVID-19 antibody test passes first major trials in UK with 98.6 per cent accuracy – The…
The fingerprick tests, which can tell within 20 minutes if a person has ever been exposed to the coronavirus
British ministers…
Bharat Biotech commences human trial of COVAXIN at PGI Rohtak
Three subjects were enrolled today. All have tolerated the vaccine very well, informed Anil Vij, Health Minister of Haryana…
TIFAC releases report on status, issues, technology readiness and challenges in API production
It was released along with a white paper on ‘Focused Interventions for ‘Make in India’: Post COVID 19’ which brought out the…
Zydus starts human trials of ZyCoV-D, its COVID-19 vaccine
The company will be enrolling over 1000 subjects across multiple clinical study sites in India for Adaptive Phase I/ II clinical…
Researchers find key element in human antibodies against COVID-19
The study results can facilitate the design of vaccine agents that can elicit a strong neutralising antibody response, say…
CSIR seeks regulatory nod for clinical trials using combination of antivirals and HDTs against…
In collaboration with Laxai Life Sciences, it aims to determine the safety and efficacy of three combination drugs…
X-ray structure analysis gives detailed insights into bacterial molecular factory
A team of the Technical University of Munich (TUM) and the Goethe University Frankfurt has now succeeded in investigating the…